Literature DB >> 2499578

Free sphingosine formation from endogenous substrates by a liver plasma membrane system with a divalent cation dependence and a neutral pH optimum.

C W Slife1, E Wang, R Hunter, S Wang, C Burgess, D C Liotta, A H Merrill.   

Abstract

Long-chain (sphingoid) bases may serve as another category of "lipid second messenger" because they inhibit protein kinase C and affect multiple cellular functions. Free sphingosine has been found in rat liver (Merrill, A. H., Jr., Wang, E., Mullins, R. E., Jamison, W. C. L., Nimkar, S., and Liotta, D. C. (1988) Anal. Biochem. 171, 373-381); hence, this study determined if liver plasma membranes contain free long-chain bases and have the ability to form them from endogenous enzymes and substrates. Isolated plasma membranes contained 0.45 nmol of sphingosine/mg of protein which, based on the recovery of the membranes, was equivalent to 3.5 +/- 1.2 nmol/g of liver and at least half of the total free sphingosine in liver. When the membranes were incubated at 37 degrees C, the amount increased at an initial rate of 5-25 pmol/min/mg, resulting in a 2-3-fold increase over an hour. Sphingosine formation required divalent cations, was optimal at neutral to alkaline pH, and was temperature-dependent. Activities with these characteristics were not identified in microsomes or lysosomes (lysosomal activities with acidic pH optima were detected, however); hence, they appear to reflect a separate plasma membrane system. Sphingosine formation was stimulated by ceramides either added exogenously or formed endogenously by treating the membranes with sphingomyelinase (but not endoglycoceramidase). Sphingomyelin hydrolysis to ceramide was also observed during incubation of the plasma membranes alone. Some of the properties of this system resembled the neutral sphingomyelinase and ceramidase activities of liver. While the physiological significance of this endogenous sphingosine is not known, this system has the appropriate subcellular location to provide sphingosine as a participant in signal transduction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499578

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Remodeling of sphingolipids by plasma membrane associated enzymes.

Authors:  Massimo Aureli; Nicoletta Loberto; Vanna Chigorno; Alessandro Prinetti; Sandro Sonnino
Journal:  Neurochem Res       Date:  2010-12-23       Impact factor: 3.996

Review 2.  Cell regulation by sphingosine and more complex sphingolipids.

Authors:  A H Merrill
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

3.  Long-chain (sphingoid) bases inhibit multistage carcinogenesis in mouse C3H/10T1/2 cells treated with radiation and phorbol 12-myristate 13-acetate.

Authors:  C Borek; A Ong; V L Stevens; E Wang; A H Merrill
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

4.  Sphingosine enhances platelet aggregation through an increase in phospholipase C activity by a protein kinase C-independent mechanism.

Authors:  T Hashizume; T Sato; T Fujii
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

5.  The role of sphingomyelin in phosphatidylcholine metabolism in cultured human fibroblasts from control and sphingomyelin lipidosis patients and in Chinese hamster ovary cells.

Authors:  M W Spence; H W Cook; D M Byers; F B Palmer
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

6.  Identification, partial purification, and localization of a neutral sphingomyelinase in rabbit skeletal muscle: neutral sphingomyelinase in skeletal muscle.

Authors:  N Ghosh; R Sabbadini; S Chatterjee
Journal:  Mol Cell Biochem       Date:  1998-12       Impact factor: 3.396

7.  The long-chain sphingoid base of sphingolipids is acylated at the cytosolic surface of the endoplasmic reticulum in rat liver.

Authors:  K Hirschberg; J Rodger; A H Futerman
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

8.  Sphingomyelinase stimulates 2-deoxyglucose uptake by skeletal muscle.

Authors:  J Turinsky; G W Nagel; J S Elmendorf; A Damrau-Abney; T R Smith
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

9.  Use of D-erythro-sphingosine as a pharmacological inhibitor of protein kinase C in human platelets.

Authors:  W A Khan; S W Mascarella; A H Lewin; C D Wyrick; F I Carroll; Y A Hannun
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

10.  Sphingosine kinase-1 associates with integrin {alpha}V{beta}3 to mediate endothelial cell survival.

Authors:  Jennifer R Gamble; Wai Y Sun; Xiaochun Li; Christopher N Hahn; Stuart M Pitson; Mathew A Vadas; Claudine S Bonder
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.